J. B. CHEMICALS & PHARMACEUTICALS LIMITED

J. B. Chemicals & Pharmaceuticals Limited

JBCHEPHARM

INE572A01036

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:50 2024-05-03 am EDT			5-day change	1st Jan Change
1,889 ^INR	+0.12%		+1.33%	+16.27%

Apr. 26	J. B. Chemicals & Pharmaceuticals Limited Receives Order from Joint Commissioner State Tax, Lucknow II, Lucknow	CI
Apr. 08	J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as A Non-Executive, Non-Independent Director	CI

J. B. Chemicals & Pharmaceuticals Limited Appoints Narayan Saraf as the Chief Financial Officer, with Effect from February 23, 2024

February 06, 2024 at 05:19 am EST

J. B. Chemicals & Pharmaceuticals Limited informed that the Board of Directors of the Company at its meeting held on February 6, 2024 has approved appointment of Mr. Narayan Saraf as the Chief Financial Officer of the Company with effect from February 23, 2024. Mr. Narayan Saraf is a qualified Chartered Accountant and Cost Accountant. He has ~20 years work experience in the field of Finance (Manufacturing & Distribution, Sales & Marketing, Risk Management, Business Planning & Analysis, Finance Controllership & Treasury) at Oil & Natural Gas Corporation Ltd., Hindustan Unilever Ltd., Cipla Ltd., 91 Streets Media Technologies Private Ltd. (PharmEasy), Thermo Fisher Scientific India Pvt.

Ltd. and Hygienic Research Institute Pvt. Ltd.

Latest news about J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited Receives Order from Joint Commissioner State Tax, Lucknow II, Lucknow	Apr. 26	CI
J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as A Non-Executive, Non-Independent Director	Apr. 08	CI
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Assessment Unit, Income Tax Department	Mar. 22	CI
J. B. Chemicals & Pharmaceuticals Limited Announces Demise of Ranjit Shahani, Chairman and Non-Executive, Independent Director	Mar. 09	CI
KKR Reportedly Considers Selling Controlling Stake in JB Pharma	Feb. 28	CI
Jefferies Adjusts JB Chemicals & Pharmaceuticals' Price Target to INR2,000 From INR1,970, Keeps at Buy	Feb. 08	MT
JB Chemicals' Consolidated Profit Climbs in Fiscal Q3; Shares Jump 4%	Feb. 07	MT
J.B. Pharma Seeks Acquisitions	Feb. 07	CI
Transcript : J. B. Chemicals & Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 07, 2024	Feb. 07
J. B. Chemicals & Pharmaceuticals Appoints CFO	Feb. 06	MT
JB Chemicals Names CFO	Feb. 06	MT
Indian drugmaker J B Chemicals posts Q3 profit rise on strong demand	Feb. 06	RE
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 06	CI
J. B. Chemicals & Pharmaceuticals Limited Appoints Narayan Saraf as the Chief Financial Officer, with Effect from February 23, 2024	Feb. 06	CI
J. B. Chemicals & Pharmaceuticals Limited Declares Interim Dividend for Financial Year 2023-24	Feb. 06	CI
Transcript : J. B. Chemicals & Pharmaceuticals Limited - Shareholder/Analyst Call	Dec. 22
J. B. Chemicals & Pharmaceuticals Limited Announces Execution of Trade Mark License Agreement with Novartis Innovative Therapies Ag and Promotion & Distribution Agreement with Novartis Healthcare Private Limited	Dec. 19	CI
JB Pharma Seeks Acquisitions	Nov. 24	CI
Jefferies Adjusts J.B. Chemicals & Pharmaceuticals' Price Target to INR1,680 From INR1,555, Keeps at Buy	Nov. 09	MT
Transcript : J. B. Chemicals & Pharmaceuticals Limited, Q2 2024 Earnings Call, Nov 08, 2023	Nov. 08
J.B. Chemicals Records Rise in Fiscal Q2 Consolidated Net Profit	Nov. 08	MT
J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as an Additional Director	Nov. 07	CI
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 07	CI
J.B. Chemicals' CFO Resigns	23-09-07	MT
J. B. Chemicals & Pharmaceuticals Limited Announces Cessation of Lakshay Kataria, Chief Financial Officer and Key Managerial Personnel, Effective November 30, 2023	23-09-07	CI

Chart J. B. Chemicals & Pharmaceuticals Limited

Duration

Period

Chart J. B. Chemicals & Pharmaceuticals Limited

More charts

Company Profile

J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.

Sector

Pharmaceuticals

Calendar

2024-05-22 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for J. B. Chemicals & Pharmaceuticals Limited

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,889 INR

Average target price

1,882 INR

Spread / Average Target

-0.37%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
J. B. CHEMICALS & PHARMACEUTICALS LIMITED	+16.27%	3.52B
ELI LILLY AND COMPANY	+26.08%	662B
NOVO NORDISK A/S	+21.85%	546B
JOHNSON & JOHNSON	-4.77%	359B
MERCK & CO., INC.	+16.97%	323B
ABBVIE INC.	+5.69%	290B
ASTRAZENECA PLC	+13.68%	234B
NOVARTIS AG	+3.65%	198B
ROCHE HOLDING AG	-11.12%	194B
AMGEN INC.	+8.08%	167B

Other Pharmaceuticals